Table 4.
(1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | |
---|---|---|---|---|---|---|---|---|
Additional verified users for 100 doses subsidized (Nb-Na) |
Additional takers for 100 doses subsidized (Tb-Ta) |
Doses fully subsidized per marginal user col (1)/ col (2) |
Full-dose equivalent for inframarginal users (Table 1 col(3) × 1/2) |
Full-dose equivalent subsidy for inframarginal users, per marginal user col (4)/ col (2) |
Total additional doses provided per new user col (3) + col (5) |
Cost per addi- tional DALY saved, USD* |
Cost per addi- tional life saved, USD* |
|
Policy change considered: |
||||||||
1. Cost-sharing to free delivery |
21.5 | 86.6 | 4.03 | 6.70 | 0.31 | 4.34 | 182 | 5,520 |
2. Cost-sharing to vouchers |
20.5 | 27.7 | 1.35 | 6.70 | 0.33 | 1.68 | 70 | 2,134 |
3. Vouchers to free delivery |
1.00 | 58.9 | 58.9 | 0 | 0 | 58.9 | 2,475 | 74,921 |
Notes: Calculations reflect material cost of water treatment solution only; differences in delivery costs are not included. What we call a dose is a yearly dose (12 bottles of 150mL). At the time of writing the exchange rate is Ksh 103 to USD 1, thus a yearly dose costs 12×20 / 103 = USD 2.33.
See Supplementary Materials for assumptions used in calculations of costs per DALY and cost per life saved.